C160524Level 6
Bendamustine/Brentuximab Vedotin Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of bendamustine and brentuximab vedotin that can be used for the treatment of Hodgkin lymphoma (HL), T-cell lymphomas, and mycosis fungoides/Sezary syndrome.
**Synonyms:** - Adcetris/Bendamustine - Bendamustine and Brentuximab vedotin - Bendamustine-Brentuximab Vedotin - Bendamustine/Adcetris - Bendamustine/Brentuximab Vedotin - Bendeka/Adcetris - Brentuximab Vedotin-Bendamustine - Brentuximab Vedotin/Bendamustine - Brentuximab Vedotin/Bendamustine Regimen
GET
/api/v1/systems/nci_thesaurus/nodes/C160524Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.